Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

pneumococcal disease

FDA sets new date for Eliquis review in atrial fibrillation

US regulator had asked for more data from Pfizer and BMS

Pfizer calls on pharmacists to promote medicine adherence

Unused medicines cost NHS England £300m per year

European Commission launches iCoach app to help smokers quit

The mobile anti-smoking campaign is part of the EC's on-going Ex-smokers are Unstoppable push

- PMLiVE

European Commission takes quit smoking campaign mobile

New iCoach Android and iPhone app is part of the EC's on-going Ex-smokers are Unstoppable push

- PMLiVE

Pfizer’s RA drug tofacitinib tops methotrexate in phase III

Trial results back drug as major new treatment in rheumatoid arthritis

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

Europe developing roadmap for mHealth use and acceptance

EU's MovingLife project is currently consulting on mHealth needs and requirements

- PMLiVE

Pfizer’s Andrew Thomas takes up UK comms agency role

Joins London-based Red Door Communications as head of international

Pfizer gets US approval for leukaemia drug Bosulif

FDA grants the tyrosine kinase inhibitor a licence to treat chronic myelogenous leukaemia

- PMLiVE

Pfizer’s Inlyta gets EU approval for advanced kidney cancer

Available as second-line therapy after treatment with pharma firm's own Sutent

- PMLiVE

European Commission wants tougher anti-smoking measures to halt spread of chronic diseases

Large number of young smokers will lead to further problems says EC's Martin Seychell at ERS congress

- PMLiVE

Pfizer dealt another blow as Torisel fails kidney cancer trial

Results are another setback in company's bid to extend the indications for its mTOR inhibitor

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links